MacroGenics, Inc. (NASDAQ:MGNX) Q4 2024 Earnings Call Transcript March 20, 2025
MacroGenics, Inc. misses on earnings expectations. Reported EPS is $-0.25 EPS, expectations were $-0.23.
Operator: Good afternoon. We will begin the MacroGenics Fourth Quarter and Full Year 2024 Corporate Progress and Financial Results Conference Call in just a moment. All participants are in a listen-only mode. And we will conduct a question-and-answer session at the conclusion of the call. At this point, I will...
